ScoreWhy is bioMérieux SA ?
1
Flat results in Dec 24
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.81%
- INTEREST COVERAGE RATIO(Q) Lowest at 3,820.31
- INTEREST(Q) Highest at EUR 12.8 MM
2
With ROE of 12.50%, it has a Very Expensive valuation with a 3.38 Price to Book Value
- Over the past year, while the stock has generated a return of 4.79%, its profits have risen by 23% ; the PEG ratio of the company is 1.2
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is bioMérieux SA for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
bioMérieux SA
4.79%
1.37
22.01%
France CAC 40
8.73%
0.52
16.76%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.46%
EBIT Growth (5y)
10.49%
EBIT to Interest (avg)
67.90
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
0.94
Tax Ratio
22.70%
Dividend Payout Ratio
24.56%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
18.06%
ROE (avg)
13.41%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
3.38
EV to EBIT
21.08
EV to EBITDA
13.83
EV to Capital Employed
3.38
EV to Sales
3.23
PEG Ratio
1.17
Dividend Yield
NA
ROCE (Latest)
16.01%
ROE (Latest)
12.50%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for bioMérieux SA
Net Sales
Highest at EUR 2,078 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (EUR MM)
Operating Profit
Highest at EUR 489 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (EUR MM)
Operating Profit Margin
Highest at 23.53 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at EUR 277.7 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (EUR MM)
Dividend per share
Highest at EUR 4.38
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (EUR)
Raw Material Cost
Fallen by -1.41% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
At EUR 189.3 MM has Grown at 38.99%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (EUR MM)
Here's what is not working for bioMérieux SA
Interest Coverage Ratio
Lowest at 3,820.31
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Inventory Turnover Ratio
Lowest at 1.81% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Interest
Highest at EUR 12.8 MM
in the last five periods and Increased by 300% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (EUR MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
